ArticlePharmaceutics2019

Evaluation of Tumor-Targeting Properties of an Antagonistic Bombesin Analogue RM26 Conjugated with a Non-Residualizing Radioiodine Label Comparison with a Radiometal-Labelled Counterpart.

Maryam Oroujeni et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.